Bg pattern

RELEPOST 20 MG/G CUTANEOUS BAR

Prescription review online

Prescription review online

A doctor will review your case and decide whether a prescription is medically appropriate.

Talk to a doctor about this medicine

Talk to a doctor about this medicine

Discuss your symptoms and possible next steps in a quick online consultation.

This page is for general information. Consult a doctor for personal advice. Call emergency services if symptoms are severe.
About the medicine

How to use RELEPOST 20 MG/G CUTANEOUS BAR

Translated with AI

This page provides general information and does not replace a doctor’s consultation. Always consult a doctor before taking any medication. Seek urgent medical care if symptoms are severe.

Show original

Introduction

Package Leaflet: Information for the User

Relepost 20 mg/g Cutaneous Bar

Tripelennamine Hydrochloride

Read the entire package leaflet carefully before starting to use this medication, as it contains important information for you.

Follow the administration instructions of the medication contained in this package leaflet exactly

or as indicated by your doctor or pharmacist.

  • Keep this package leaflet, as you may need to read it again.
  • If you need advice or more information, consult your pharmacist.
  • If you experience side effects, consult your doctor or pharmacist, even if they are not listed in this package leaflet. See section 4.

Consult a doctor if it worsens or does not improve after 4 days.

  • You should consult a doctor if you experience any side effects or if the condition worsens or does not improve after 4 days.

Contents of the Package Leaflet

  1. What is Relepost and what is it used for
  2. What you need to know before using Relepost
  3. How to use Relepost
  4. Possible side effects
  5. Storage of Relepost
  6. Contents of the pack and further information

1. What is Relepost and what is it used for

It contains tripelennamine hydrochloride as the active ingredient, which is an antihistamine, a medication used on the skin to eliminate or reduce the effects of allergies, thereby reducing symptoms such as itching or pain caused by certain agents.

Relepost is used for the temporary relief of itching, pain, or stinging due to insect bites or contact with jellyfish or nettles, or itching due to mild skin irritations.

Doctor consultation

Not sure if this medicine is right for you?

Discuss your symptoms and treatment with a doctor online.

2. What you need to know before using Relepost

Do not use Relepost:

  • If you are allergic to tripelennamine or related compounds or to any of the other components of this medication (listed in section 6).
  • If you have a skin inflammation with fluid secretion and/or small blisters (exudative and/or vesicular dermatitis).
  • In children under 2 years of age.
  • On large areas of skin and in case of skin inflammation around the affected area.

Warnings and precautions

Consult your doctor or pharmacist before starting to use Relepost.

Do not use on open wounds.

In case of allergy to the active ingredient of this medication or the related substance ethylenediamine, you may also have cross-sensitivity to antihistamine medications, such as aminophylline or hydroxyzine.

Children

This medication should not be used in children under 2 years of age.

In children over 2 years and under 6, the doctor or pharmacist should assess its use, as although absorption is minimal, sedative effects and others may occur.

Other medications and Relepost

Inform your doctor or pharmacist if you are using, have recently used, or may need to use any other medication.

No interactions with this medication are known.

Pregnancy, breastfeeding, and fertility

If you are pregnant or breastfeeding, think you may be pregnant, or plan to become pregnant, consult your pharmacist before using this medication.

Relepost can be used during pregnancy under prescription and during breastfeeding.

No data are available on whether Relepost affects fertility.

Driving and using machines

Relepost has no influence on the ability to drive and use machines.

Relepost contains propylene glycol (E1520).

This medication contains 715 mg of propylene glycol per gram.

Propylene glycol may cause skin irritation.

3. How to use Relepost

Follow the administration instructions of the medication contained in this package leaflet exactly or as indicated by your doctor or pharmacist. If in doubt, ask your doctor or pharmacist.

The recommended dose is:

  • Adults and children over 6 years of age:

Relepost is applied to the affected skin area. Repeat if necessary, up to 3 or 4 times a day.

For cutaneous use.

Slide the bar with a gentle massage on the affected area.

Apply only to small-sized conditions (no larger than the size of the palm of the hand) for short-term treatments (maximum 7 days).

Do not use on damaged skin (or on wounds).

Use in children

This medication should not be used in children under 2 years of age.

In children over 2 years and under 6, the doctor or pharmacist should assess its use.

If you use more Relepost than you should

With a cutaneous bar, overdose is not relevant.

In case of systemic intoxication, symptoms may include lethargy, agitation, confusion, tinnitus, blurred vision, dilated pupils, dry mouth, flushing, fever, tremors, insomnia, and hallucinations. Toxic reactions have been reported in a child (agitation, convulsions, ...) in whom it was used on a large area of the body.

In case of overdose or accidental ingestion, go immediately to a medical center, consult your doctor or pharmacist, or call the Toxicology Information Service, phone 91 562 04 20, indicating the medication and the amount ingested.

If you forget to use Relepost

Do not use a double dose to make up for forgotten doses.

Apply the dose as soon as you remember and the next dose at the usual time.

If you have any other doubts about the use of this medication, ask your doctor or pharmacist.

Medicine questions

Started taking the medicine and have questions?

Discuss your symptoms and treatment with a doctor online.

4. Possible side effects

Like all medications, this medication can cause side effects, although not everyone experiences them.

The most characteristic adverse reaction that may occur is irritation and mild allergic reactions on contact.

Reporting side effects

If you experience any type of side effect, consult your doctor or pharmacist, even if it is a possible side effect not listed in this package leaflet. You can also report them directly through the Spanish Medication Surveillance System for Human Use: https://www.notificaRAM.es. By reporting side effects, you can contribute to providing more information on the safety of this medication.

5. Storage of Relepost

Keep this medication out of the sight and reach of children.

Store in the original packaging, tightly closed. Do not store at a temperature above 25°C.

Do not refrigerate or freeze.

Do not use this medication after the expiration date shown on the box and on the base of the cutaneous bar applicator after CAD. The expiration date is the last day of the month indicated.

Do not use this medication if you notice a color different from white or a soft product consistency.

Medications should not be disposed of through wastewater or household waste. Deposit the packaging and medications you no longer need at the SIGRE point in the pharmacy. If in doubt, ask your pharmacist how to dispose of the packaging and medications you no longer need. This will help protect the environment.

6. Contents of the pack and further information

Composition of Relepost

The active ingredient is tripelennamine hydrochloride. Each gram contains 20 mg of tripelennamine hydrochloride (2%).

The other components (excipients) are: propylene glycol (E1520), sodium stearate, and water.

Appearance of the product and contents of the pack

White, oval-shaped, and consistent cutaneous bar.

Each applicator contains 5.7 grams.

Marketing authorization holder and manufacturer

Marketing authorization holder

Perrigo España S.A.

Pza. Xavier Cugat, 2 – Edif. D, Pl. 1ª

08174 Sant Cugat del Vallès (Barcelona), España

Manufacturer

Medgenix Benelux NV

Vliegveld 21

Wevelgem, 8560

Belgium

Date of the last revision of this package leaflet:March 2024

Detailed information on this medication is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) (http://www.aemps.gob.es/).

Online doctors for RELEPOST 20 MG/G CUTANEOUS BAR

Discuss questions about RELEPOST 20 MG/G CUTANEOUS BAR, including use, safety considerations and prescription review, subject to medical assessment and local regulations.

5.0 (3)
Doctor

Tomasz Grzelewski

Dermatology 21 years exp.

Dr Tomasz Grzelewski is an MD, PhD specialist in allergy, paediatrics, general practice and sports medicine, with a clinical focus on dermatology, endocrinology, allergology and sports-related health. He has more than 20 years of clinical experience and completed his medical training at the Medical University of Łódź, where he defended his PhD thesis with distinction. His doctoral research was recognised by the Polish Society of Allergology for its innovative contribution to the field. Throughout his career, he has gained extensive expertise in diagnosing and managing a wide range of allergic and paediatric conditions, including modern allergen desensitisation techniques.

For five years, Dr Grzelewski served as the Head of two paediatric departments in Poland, managing complex clinical cases and leading multidisciplinary teams. He also worked in medical centres in the United Kingdom, gaining experience across both primary care and specialist environments. With over a decade of telemedicine experience, he has provided online consultations across Europe and is valued for his clear, structured and evidence-based medical guidance.

Dr Grzelewski is actively involved in clinical programmes focused on modern anti-allergic therapies. As a Principal Investigator, he leads research projects on sublingual and oral allergen desensitisation, supporting evidence-based progress in allergy treatment for both children and adults.

In addition to his background in allergology and paediatrics, he completed dermatology studies through the Cambridge Education Group (Royal College of Physicians of Ireland) and a Clinical Endocrinology course at Harvard Medical School. This advanced training enhances his ability to manage skin manifestations of allergies, atopic conditions, urticaria, endocrine-related symptoms and complex immunological reactions.

Patients commonly seek his care for:

  • seasonal and perennial allergies
  • allergic rhinitis and chronic nasal symptoms
  • asthma and breathing difficulties
  • food and medication allergies
  • urticaria, atopic dermatitis and skin reactions
  • recurrent infections in children
  • sports-related health questions
  • general family medicine concerns
Dr Tomasz Grzelewski is known for his clear communication style, structured medical approach and ability to explain treatment options in a concise and accessible way. His multidisciplinary background across allergy, paediatrics, dermatology and endocrinology allows him to provide safe, up-to-date and comprehensive care for patients of all ages.
Camera Book a video appointment
€80
5.0 (2)
Doctor

Alexander Nazarchuk

Allergology 7 years exp.

Dr. Alexander Nazarchuk is a physician specialising in allergology and internal medicine. He provides online consultations for adults, following the principles of evidence-based medicine — no outdated treatments or unnecessary tests, with clear explanations and a personalised approach. He helps patients with a wide range of allergic and therapeutic conditions, from common day-to-day complaints to complex cases involving allergies, gastrointestinal issues, cardiovascular concerns, respiratory symptoms, and more.

You can consult Dr. Nazarchuk for:

  • Test interpretation and guidance on diagnostic plans.
  • Allergic rhinitis, hay fever, bronchial asthma (including severe cases).
  • Food and drug allergies, skin rashes, angioedema.
  • Atopic dermatitis, urticaria, contact allergies.
  • Allergen-specific immunotherapy (AIT) – initiation and ongoing management.
  • Abdominal pain, bloating, changes in bowel habits, nausea, heartburn.
  • High blood pressure and adjustment of baseline antihypertensive therapy.
  • Hyperlipidaemia and elevated cholesterol.
  • Cough, nasal congestion, fever, sore throat.
  • Anaemia, including iron deficiency and related conditions.
  • Other issues related to allergology and internal medicine.

During consultations, Dr. Nazarchuk takes a thorough, structured approach — analysing symptoms, identifying potential causes, and helping patients make informed decisions. Whether treatment, further investigation, or monitoring is needed, he explains each step clearly so you understand your health and how best to manage it.

Camera Book a video appointment
€55
0.0 (0)
Doctor

Marta Reguero Capilla

Allergology 8 years exp.

Dr Marta Reguero Capilla is an allergist and immunologist who works with both adults and children. She specialises in the diagnosis, treatment, and ongoing management of allergic and immune-related conditions through online consultations.

In her practice, Dr Reguero Capilla helps patients understand the causes of their symptoms, review test results, and choose appropriate treatment or monitoring strategies. Her consultations are suitable both for first-time assessments and for follow-up care over time.

Patients commonly consult Dr Marta Reguero Capilla for:

  • allergic rhinitis, seasonal allergies, and perennial allergy symptoms;
  • allergic conditions in adults and children;
  • bronchial asthma and allergy-related respiratory symptoms;
  • urticaria (acute and chronic) and angioedema;
  • food allergies and reactions to foods, additives, or medications;
  • atopic dermatitis, allergic rashes, and persistent itching;
  • unexplained or recurrent allergic reactions;
  • interpretation of laboratory tests, allergy testing, and immunology results;
  • immune system concerns, frequent infections, and reduced immune response;
  • ongoing medical follow-up and treatment adjustment.
Dr Reguero Capilla works in a structured and attentive manner, explaining medical decisions clearly and helping patients make informed choices about their own health or their child’s care.

When clinically appropriate, she may provide recommendations for further tests or referrals that patients can use within Spanish medical networks, including Sanitas and DKV, in accordance with the terms and conditions of those services.

Camera Book a video appointment
€60

Frequently Asked Questions

Is a prescription required for RELEPOST 20 MG/G CUTANEOUS BAR?
RELEPOST 20 MG/G CUTANEOUS BAR does not require a prescription in Spain. You can check with a doctor online whether this medicine may be appropriate for your situation.
What is the active substance in RELEPOST 20 MG/G CUTANEOUS BAR?
The active ingredient in RELEPOST 20 MG/G CUTANEOUS BAR is tripelennamine. This information helps identify medicines with the same composition but different brand names.
Who manufactures RELEPOST 20 MG/G CUTANEOUS BAR?
RELEPOST 20 MG/G CUTANEOUS BAR is manufactured by Perrigo Espana S.A.. Pharmacy brands and packaging may differ depending on the distributor.
Which doctors can assess the use of RELEPOST 20 MG/G CUTANEOUS BAR online?
Doctors such as Family doctors, Psychiatrists, Dermatologists, Cardiologists, Endocrinologists, Gastroenterologists, Pulmonologists, Nephrologists, Rheumatologists, Hematologists, Infectious disease physicians, Allergists, Geriatricians, Paediatricians, Oncologists may assess whether RELEPOST 20 MG/G CUTANEOUS BAR is appropriate, depending on your situation and local regulations. You can book an online consultation to discuss your symptoms and possible next steps.
What are the alternatives to RELEPOST 20 MG/G CUTANEOUS BAR?
Other medicines with the same active substance (tripelennamine) include DERMAPIC 1 mg/g GEL, DIMESTIL 1mg/g GEL, FENISTIL 1 mg/g GEL. These may have different brand names or formulations but contain the same therapeutic ingredient. Always consult a doctor before switching or starting a new medicine.
bg-pattern-dark

Stay informed about Oladoctor

News about new services, product updates and useful information for patients.

Follow us on social media